Calumet (CLMT) Stock Falls As Cash Flow Strength Meets Equity Risk

Calumet stock dropped 5.7% to close at US$39.48 after its latest earnings, even though the quarter featured one clear headline. The company produced US$175m of adjusted earnings before interest, tax, depreciation and amortization, and generated more than US$90m of cash from operations, while continuing to pay down debt.

In the short term, traders are reacting to a red price screen. Over a multi year horizon, the real story is the balance sheet repair. Management is retiring higher cost obligations and relying on that cash engine to reduce negative equity.

Love Calumet’s cash generation and debt paydown but worried about balance sheet risk and equity deficits hanging over the story? Consider screening for companies with similar cash engines but stronger fundamentals using the list of solid balance sheet and fundamentals stocks (49 results).

Q2 2026 Earnings Summary

• Revenue, Q2 2026 vs. Q2 2025: US$1,445.1m vs. US$1,026.6m (higher revenue year on year)
• Net Income/Loss, Q2 2026 vs. Q2 2025: loss of US$95.9m vs. loss of US$147.9m (smaller loss year on year)
• Basic EPS, Q2 2026 vs. Q2 2025: loss of US$1.09 per share vs. loss of US$1.70 per share (smaller loss per share year on year)
• Adjusted EBITDA, Q2 2026 vs. Q2 2025: US$175m vs. not disclosed for the prior period (strong cash earnings performance in the latest quarter)

Prefer clean visuals instead of another dense block of earnings tables and footnotes? See a full picture of Calumet’s balance sheet, including debt trends and equity position, laid out in simple charts through our company report for Calumet.

Calumet’s Bull Story: Cash Engine Now Hitting Key Marks

The bullish pitch around Calumet is that a high margin renewables and specialty engine can fund debt reduction and eventually reshape the equity story. Q2 gives hard evidence that this is starting to happen. Adjusted EBITDA of US$175m and more than US$90m of cash from operations backed actual debt retirement, with restricted group leverage already under 4x and management signaling a move below 3x next quarter as more high cost paper is retired.

On operations, the thesis that specialty and Montana Renewables can carry the load also gained support. Specialty Products & Solutions generated US$161.7m of adjusted EBITDA with record specialty production. Montana Renewables still produced roughly US$17m of adjusted EBITDA despite downtime and foregone MaxSAF-150 margin, while completing a successful performance test of the MaxSAF catalyst and locking in evergreen SAF contracts at a premium to renewable diesel.

Reveal where the surface looks calm for Calumet, but the multi year earnings and cash flow models start to disagree on the next inflection point by accessing the analyst estimates for Calumet.

Calumet Bear Case: Policy, Capital and Cash Still Under Scrutiny

The bearish view on Calumet says regulatory risk, capital access and legacy exposure could keep pressure on returns even after a strong year. Q2 does not close that file. Montana Renewables EBITDA of about US$17m came with meaningful downtime and roughly US$40m of foregone MaxSAF 150 margin, so the renewables engine is not yet running at the scale that would fully offset policy or credit volatility.

Bears also worry that financing remains fragile. Management is paying down high cost paper and restricted group leverage has already fallen below 4x, which pushes against the idea that ESG driven capital flight is blocking progress. However, Calumet still reports a quarterly net loss of US$95.9m and working capital absorbed roughly US$70m of cash. That is clear evidence that balance sheet risk has eased but not fully cleared and that free cash flow remains exposed to execution and policy shifts.

After working capital absorbed US$70m and Montana Renewables produced modest EBITDA with downtime, review our risk analysis for Calumet which shows 1 important warning sign to see if these pressures signal deeper structural issues.

Stay Ahead With Simply Wall St

If Calumet’s strong cash generation alongside ongoing debt reduction has your attention, register for free with Simply Wall St and add it to a Watchlist to track price moves against fair value and wait for a setup that fits your plan. After you take a position, keep focused on what actually matters by using the Portfolio Command Center to cut through day to day noise and surface only the key updates on earnings, balance sheet progress and cash flow. For a longer term view, tap into crowd insights and see how other investors are thinking about Calumet’s risks and catalysts through the Community. By identifying potential turning points early, you may be able to better highlight catalysts and risks before the wider market reacts.

Seeking Smart Alternatives Beyond Calumet?

Fresh stock ideas can move from quiet to breakout fast. Use these screeners while the data is still under the radar for now. Get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com